Introduction: In France, 6.300 new cases of genital, anal and ENT cancers attributable to HPV are recorded each year. Vaccination is the only effective prevention against the transmission of this highly contagious STI. However, vaccination coverage is too low to provide herd immunity. The aim of this study was to assess the position of parents, who are key decision-makers, regarding HPV vaccination of their child. Material and method: We conducted a prospective study between October 13th and December 31st, 2021 in 8 volunteer middle schools in Calvados. Parents of secondary school students aged 11 to 14 were interviewed through an anonymous statistical survey platform on which the survey was available. Results: Among the 1.154 parents who p...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
International audienceIntroductionAs part of an analysis on the extension of the HPV vaccination to ...
Introduction: In France, 6.300 new cases of genital, anal and ENT cancers attributable to HPV are re...
Introduction: In France, 6.300 new cases of genital, anal and ENT cancers attributable to HPV are re...
ln 99% of cases, cervical cancers result from human papillomavirus (HPV) infection, 70% are caused b...
La vaccination contre le papillomavirus humain (HPV) est recommandée en France depuis avril 2007 che...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
Introduction : La couverture vaccinale contre les HPV est, en France, l’une des plus faibles d’Europ...
International audienceBACKGROUND:In 2015, the vaccine against human Papillomavirus (hPV) was recomme...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
International audienceIntroductionAs part of an analysis on the extension of the HPV vaccination to ...
Introduction: In France, 6.300 new cases of genital, anal and ENT cancers attributable to HPV are re...
Introduction: In France, 6.300 new cases of genital, anal and ENT cancers attributable to HPV are re...
ln 99% of cases, cervical cancers result from human papillomavirus (HPV) infection, 70% are caused b...
La vaccination contre le papillomavirus humain (HPV) est recommandée en France depuis avril 2007 che...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
Introduction : La couverture vaccinale contre les HPV est, en France, l’une des plus faibles d’Europ...
International audienceBACKGROUND:In 2015, the vaccine against human Papillomavirus (hPV) was recomme...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
International audienceBACKGROUND: In 2015, the vaccine against human Papillomavirus (hPV) was recomm...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
In France, vaccination against papillomavirus is recommended for teenagers between the age of 11 and...
International audienceIntroductionAs part of an analysis on the extension of the HPV vaccination to ...